Growing awareness of the benefits of menopause hormone therapy (MHT) has caused a sharp rise in demand. However, many doctors are not adequately trained to prescribe it, raising concerns about patient safety. In New Zealand, the supply has become so tight that the country’s drug-funding agency, Pharmac, has temporarily rationed supplies, according to a report from Medical Xpress.

Key takeaways

  • Demand for menopause hormone therapy has increased significantly as awareness of its benefits grows.
  • Manufacturers cannot keep up with demand, leading to temporary rationing in New Zealand.
  • Many doctors lack sufficient training on MHT, which can lead to inappropriate prescribing or underprescribing.
  • Experts call for better education and clearer guidelines for healthcare providers.

What is driving the rise in demand for MHT?

For years, menopause was often treated as a natural stage to be endured, and hormone therapy was underused due to safety concerns from older studies. More recent research has clarified that MHT is safe and effective for many women when started at the right time. Public awareness campaigns, celebrity endorsements, and social media discussions have helped destigmatize treatment and inform women about options for managing symptoms such as hot flashes, night sweats, and vaginal dryness. As a result, more patients are asking their doctors for prescriptions.

Training gaps leave doctors unprepared

Despite the surge in demand, medical education on menopause remains limited. Many physicians receive little to no formal training on MHT during medical school or residency. According to the Medical Xpress report, this knowledge gap can lead to inconsistent prescribing practices. Some doctors may refuse to prescribe MHT at all, while others may not follow up with patients to monitor risks. Specialists in women’s health say that primary care providers, who are often the first point of contact, need better access to evidence-based guidelines and continuing education.

Supply bottlenecks and rationing

The increased demand has caught manufacturers off guard. In New Zealand, Pharmac announced it would temporarily ration certain MHT products to ensure equitable access. The agency cited global supply chain disruptions and a sharp uptick in prescriptions. Similar shortages have been reported in other countries, including parts of the United States. The rationing means some patients may face delays or have to switch to alternative treatments, which can be difficult if they have found a regimen that works.

What patients can do

Women experiencing menopause symptoms who are interested in MHT should seek a healthcare provider who is knowledgeable about the therapy. If a doctor seems unsure, patients can ask for a referral to a gynecologist or a menopause specialist. Keeping a symptom diary can also help guide the conversation. The North American Menopause Society maintains a list of certified practitioners. It is also important for patients to understand that MHT is not suitable for everyone; a thorough risk assessment is needed.

Frequently Asked Questions

What is menopause hormone therapy?

Menopause hormone therapy (MHT), also called hormone replacement therapy (HRT), involves taking estrogen and sometimes progesterone to relieve symptoms caused by the decline in natural hormones during menopause. It is available in various forms, including pills, patches, gels, and vaginal creams.

Why are some doctors reluctant to prescribe MHT?

Some doctors are cautious because of findings from the Women’s Health Initiative study in the early 2000s, which linked MHT to increased risks of breast cancer and heart disease. Later analyses showed those risks were largely related to older age at initiation and specific hormone types. However, many physicians still lack updated training, leading to hesitation or refusal to prescribe.

How can I find a doctor trained in MHT?

You can search for certified menopause practitioners through the North American Menopause Society’s online directory. Asking your primary care provider for a referral to a gynecologist or reproductive endocrinologist is another option. Telehealth services that specialize in menopause are also increasingly available.

This is an original report by Vital Signs Today, informed by reporting from Medical Xpress. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.